Organisation paid for research Program year 2022 Source: CMS Open Payments

Centex Studies

Neither a doctor nor a teaching hospital

Research payments

$99,171

79 payments

Through program year 2022, Centex Studies is reported as receiving $99,171 in research payments, across 79 payments.

By program year

4 rows
Year Kind Amount Payments
2022 Research $36,720 19
2021 Research $51,997 47
2020 Research $1,844 4
2019 Research $8,611 9

Breakdown

Who paid Research payments · program years 2019–2022
  1. Exeltis, USA Inc. $45,378 30 payments
  2. Novartis Pharmaceuticals Corporation $25,310 2 payments
  3. AbbVie, Inc. $10,740 6 payments
  4. Allergan Inc. $10,455 13 payments
  5. Boehringer Ingelheim RCV GmbH & Co KG $7,289 28 payments
Studies the money was for Research payments · program years 2019–2022
  1. A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles $37,037 19 payments
  2. A 5-Year, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Assessing the Efficacy, Safety, and Tolerability of Intra-Articular Regimens of Lna043 Versus Placebo in Patients With Symptomatic Knee Osteoarthritis $25,310 2 payments
  3. Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants $10,740 6 payments
  4. A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant for the Prevention of Migraine in Patients With Episodic Migraine $8,452 10 payments
  5. Pivotal, Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, Tolerability of LPRI-424, 13 Cycles $8,341 11 payments
  6. POCC in NASH $7,289 28 payments
  7. A Phase 3, Multicenter, Open-Label 40-Week Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine $2,003 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record